stockrowBecton, Dickinson and Company
BDX Healthcare Medical Instruments & Supplies
Becton, Dickinson and Company’s revenue for fiscal 2025 (year ended September 2025) was $21.8 billion, up 8.24% from fiscal 2024.
- Revenue
- −9.55%
- EPS
- −31.5%
- Free cash flow
- −31.6%
- Total debt
- −22.9%
Quarter to June 2026, against a year earlier
Follow BDX
Alert me
Becton, Dickinson and Company (BDX) Revenue growth
Becton, Dickinson and Company's revenue growth over the twelve months to 30 June 2026 was −2.55%, down 10.8 percentage points from fiscal 2025 (8.24%). Over the past ten years it has ranged from −7.03% (fiscal 2020) to 32.2% (fiscal 2018); the current reading is higher than 64% of that period. That is below the Medical Instruments & Supplies industry median of 8.97% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 8.24% | 4.08 |
| FY2024 | 4.16% | 1.50 |
| FY2023 | 2.66% | 4.02 |
| FY2022 | −1.36% | (20.38) |
| FY2021 | 19.0% | 26.05 |
| FY2020 | −7.03% | (15.21) |
| FY2019 | 8.18% | (23.99) |
| FY2018 | 32.2% | 35.29 |
| FY2017 | −3.12% | (24.53) |
| FY2016 | 21.4% | (0.33) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | −9.55% | 1.03 |
| Mar 2026 | −10.6% | (12.21) |
| Dec 2025 | 1.63% | (6.72) |
| Sep 2025 | 8.35% | (2.05) |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| ISRG Intuitive Surgical, Inc. compare | 20.5% |
| WST West Pharmaceutical Services, Inc. compare | 12.6% |
| RMD ResMed Inc. compare | 9.04% |
| ALC Alcon compare | 8.34% |
| BAX Baxter International Inc. compare | 5.33% |
| COO The Cooper Companies, Inc. compare | 4.73% |
| BDX Becton, Dickinson and Company | −2.55% |
| SOLV Solventum Corporation compare | −2.84% |
| MDLN Medline Inc. compare | — |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on BDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement